INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 164 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576 | -22.5% | 18,223 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $743 | +32.9% | 18,223 | +21.4% | 0.01% | +25.0% |
| Q1 2023 | $559 | +2.0% | 15,012 | -4.4% | 0.00% | 0.0% |
| Q4 2022 | $548 | -99.9% | 15,700 | -5.5% | 0.00% | -42.9% |
| Q3 2022 | $929,000 | +46.1% | 16,609 | +35.2% | 0.01% | +40.0% |
| Q2 2022 | $636,000 | -28.8% | 12,282 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $893,000 | -40.0% | 12,282 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $1,489,000 | -10.2% | 12,282 | -0.6% | 0.01% | -11.1% |
| Q3 2021 | $1,658,000 | -23.7% | 12,357 | -69.1% | 0.01% | -40.0% |
| Q4 2020 | $2,172,000 | +176.0% | 39,935 | +0.9% | 0.02% | +150.0% |
| Q3 2020 | $787,000 | +4042.1% | 39,571 | +4331.2% | 0.01% | – |
| Q2 2020 | $19,000 | – | 893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |